Printer Friendly

NEW ENGLAND JOURNAL OF MEDICINE ARTICLE CREATES INCREASED DEMAND FOR IMEX MEDICAL SYSTEM'S DIAGNOSTIC PRODUCTS

NEW ENGLAND JOURNAL OF MEDICINE ARTICLE CREATES INCREASED DEMAND FOR
 IMEX MEDICAL SYSTEM'S DIAGNOSTIC PRODUCTS
 GOLDEN, Colo., March 19 /PRNewswire/ -- Imex Medical Systems, Inc. (NASDAQ: IMEX) announced today that demand for its diagnostic line of products has increased after The New England Journal of Medicine published a study Feb. 6 documenting the importance of screening for Peripheral Arterial Disease (PAD).
 The 10-year study conducted by Doctors Michael Criqui and Arnost Fronek at the University of California at San Diego concluded that the percentage of people with PAD increases rapidly after the age of 60 and that a PAD patient's risk of dying is up to 15 times greater than that of a person without PAD. The risk of developing heart disease can also be many times greater for people with PAD than for persons without PAD.
 As most patients with the disease do not exhibit symptoms, it is often difficult to diagnose without the use of simple noninvasive screening equipment. Imex Medical Systems has been developing diagnostic medical equipment that tests for vascular diseases for 13 years, leading the industry in supplying easy-to-use, affordable, quality products to the physician's office.
 Imex President Dennis Newman said, "We are very excited about the results of the study. Currently there are over 32 million people over the age of 65 in the United States. Based on this new study, 4 million people are at risk. Therefore, providing quality health care to these patients should be a priority for physicians. As they become more aware of the importance of vascular testing, through this study, they are contacting Imex because our products meet their needs in this area."
 In addition to PAD, over 40 million Americans are afflicted by other various forms of arterial and venous disease which have resulted in over 100,000 leg amputations, 500,000 strokes (150,000 of which were fatal) and 300,000 to 600,000 hospitalizations due to venous thrombosis and pulmonary embolisms (50,000 of which were fatal). Stroke, only one aspect of vascular disease, has cost Americans $14 billion a year.
 Founded in 1976, Imex Medical Systems manufactures and markets medical instrumentation that complements the major trends in health care including cost containment, the move to outpatient care, and earlier awareness, diagnosis and treatment of cardiovascular disease.
 -0- 3/19/92
 /CONTACT: Dennis Newman of Imex Medical, 303-431-9400, or Mike Jirik of Carl Thompson Assoc., 303-494-5472, for Imex Medical/
 (IMEX) CO: Imex Medical Systems ST: Colorado IN: MTC SU:


AL -- MN008 -- 9709 03/19/92 13:08 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 19, 1992
Words:421
Previous Article:THEIS RESEARCH ALLEGES INFRINGEMENT OF PATENTS BY AMERITECH
Next Article:MCI LOWERS IN-STATE RATES IN COLORADO
Topics:


Related Articles
IMEX MEDICAL SYSTEMS ANNOUNCES SIGNIFICANTLY INCREASED SALES FOR FISCAL SECOND QUARTER
IMEX MEDICAL SYSTEMS PURCHASES MEDACORD PVL PRODUCT LINE FROM MEDASONICS
IMEX MEDICAL SYSTEMS PURCHASES MEDACORD PVL PRODUCT LINE FROM MEDASONICS
IMEX MEDICAL SYSTEMS INTRODUCES FIRST MODULAR DIAGNOSTIC WORKSTATION WITH NEW HOLTER/ABP SYSTEM
IMEX MEDICAL SYSTEMS ANNOUNCES RECORD SALES FOR YEAR
IMEX MEDICAL SYSTEMS REPORTS RECORD SALES, DECREASED EARNINGS FOR FIRST HALF OF FISCAL 1993
IMEX MEDICAL SYSTEMS REPORTS SALES AND EARNINGS FOR 1993 THIRD QUARTER
INTERNATIONAL SALES SKYROCKET FOR IMEX
IMEX MEDICAL SYSTEMS LAUNCHES FIRST CORDLESS DOPPLER
IMEX MEDICAL SYSTEMS REPORTS REVENUE INCREASE FOR FISCAL YEAR 1995

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters